Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.
Maria Alice B FranzoiMatteo LambertiniMarcello CeppiMarco BruzzoneEvandro de AzambujaPublished in: Breast cancer research and treatment (2022)
ClinicalTrials.gov identifier: NCT02441946.